# State Street SPDR MSCI Europe Health Care UCITS ETF Accum Ptg EUR (HEAE)

**Source:** https://fundology.uk/fund/heae · ISIN IE00BKWQ0H23 · Data: TradingView (LSE closes and returns, delayed), issuer documents, ONS CPIH, FCA FIRDS

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 30/09/2026, HEAE (State Street SPDR MSCI Europe Health Care UCITS ETF Accum Ptg EUR, ISIN IE00BKWQ0H23) closed at £189.38 on the London Stock Exchange. Its ongoing charge is 0.18% a year (about £18 on £10,000). Over the five years to 30/09/2026 its total return was +26.0%, or −1.5% after UK CPIH inflation.

## Summary

State Street SPDR MSCI Europe Health Care UCITS ETF Accum Ptg EUR is an exchange-traded fund (ETF) from SPDR, launched in 2014. It tracks the MSCI Europe Health Care 35/20 Capped Index - EUR - Benchmark TR Net — large and medium-sized European companies. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.18% a year — about £18 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

Latest close: **£189.38** (30/09/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | HEAE |
| ISIN | IE00BKWQ0H23 |
| Category | Healthcare |
| Type | ETF |
| Provider | SPDR |
| Tracks | MSCI Europe Health Care 35/20 Capped Index - EUR - Benchmark TR Net |
| Income | Accumulating |
| Ongoing charge | 0.18% a year (£18 per £10,000) |
| Fund size | £372m |
| Launched | 2014 |
| Domicile | Ireland |

## Past returns (periods to 30/09/2026)

After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after ONS CPIH inflation.

| Window | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 1 year | +8.76% | +5.34% | income reinvested |
| 3 years | +8.74% | -1.88% | income reinvested |
| 5 years | +25.99% | -1.51% | income reinvested |

Returns: TradingView (delayed data). Inflation: ONS CPIH, latest month published.

## Charges compared with similar funds

Ongoing charge of State Street SPDR MSCI Europe Health Care UCITS ETF Accum Ptg EUR 0.18% a year, as of 01/10/2026: 11 of the 17 other healthcare funds charge more, 2 the same and 4 less (share classes counted once).

## Charges & eligibility

- Ongoing charges figure (OCF): **0.18%** per year
- ISA eligible: yes
- SIPP eligible: yes

## Top holdings

Largest positions (as of 30/09/2026):

| Holding | Weight |
|---|---|
| Roche | 17.61% |
| Novartis | 15.12% |
| AstraZeneca | 14.18% |
| Novo Nordisk · Class B | 7.12% |
| GSK | 5.66% |
| Sanofi | 5.18% |
| argenx | 3.46% |
| Bayer | 3.07% |
| Lonza Group | 2.78% |
| EssilorLuxottica | 2.76% |

## Where it invests

Shares of the whole fund. Bonds, cash and positions the source does not classify are shown as they come, not guessed.

### By country

Added up from the holdings SPDR publishes, as of 30/09/2026.

| Country | Weight |
|---|---|
| Switzerland | 43.0% |
| United Kingdom | 22.7% |
| France | 9.8% |
| Denmark | 9.0% |
| Germany | 7.7% |
| Belgium | 5.3% |
| Netherlands | 1.1% |
| Finland | 0.6% |
| Other countries | 0.7% |

All 37 holdings: https://fundology.uk/fund/heae/holdings

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.